FOSL2 and adult T-cell leukemia/lymphoma: The discovery of CCR4 as a downstream target of FRA-2 and JUND could in the future be exploited, being a tumour-associated antigen in adult T-cell leukaemia/lymphoma (ATLL) and CTCLs [122].